Documentarian Chronicles Diabetes Pandemic

Charles Mattocks

Charles Mattocks

With an estimated 30 million Americans living with diabetes, and 1.4 million new cases diagnosed annually, it’s the seventh leading cause of death in the United States. There are 171 medicines in development for type 1 and type 2 diabetes either in clinical trials or awaiting U.S. Food and Drug Administration approval, according to a 2016 report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Diabetes hit home for documentarian Charles Mattocks, who discovered he had type 2 diabetes after a routine visit to the doctor.

In type 1 diabetes, the body does not produce insulin. Untreated, it can affect major organs in the body, including heart, eyes, and kidneys.

In type 2 diabetes, also called hyperglycemia, the body doesn’t use insulin properly, and over time cannot maintain blood glucose at healthy levels.

Mattocks presented his documentary about chronic pain, “Trial by Fire,” at ACRP’s 2017 Meeting & Expo in Seattle. He’s back with a new reality series called “Reversed,” a chronicle of eight people from different walks of life battling diabetes.

During the 10-episode series, airing Tuesdays on Discovery Life network, Mattocks follows the diabetics as they confront the disease using traditional medical tools, bolstered by spiritual and nutritional practitioners helping to improve their lives on a number of levels beyond the disease itself. The first episode aired July 18.

“Reversed” is not a typical competitive reality show, Mattocks says, in that there are no winners and losers. “We bring people together to face the challenge within, to help them make the changes they need to make and leave as advocates.”

“It has changed lives,” Mattocks says. “The greatest impact [of the show] is awareness. If we can educate in a small way and inspire in a big way,” the show will be a success, he adds.

In September, Mattocks plans to release a documentary, “The Diabetic You.” It tells the personal stories of both type 1 and type 2 diabetics.

Author: Michael Causey